https://www.avient.com/sites/default/files/2022-06/Colorant Chromatics FEP UV Laser Marking Product Bulletin.pdf
KEY CHARACTERISTICS
• Benign marking, ensuring FEP jacketing
integrity
• Permanent marking with outstanding contrast
of 60–80%
• Meets aerospace industry standards SAE
AS4373F and EN-3475-706
• Technology applicable in PFA
MARKETS AND APPLICATIONS
Colorant Chromatics UV Laser Marking technology
for FEP is a good choice for a range of applications
within the wire and cable industry, and is
especially suited for aerospace and aviation.
https://www.avient.com/sites/default/files/2022-12/Renol Fiber Colorants Black Colorants for PET and PA Fibers Product Bulletin.pdf
KEY CHARACTERISTICS
• Excellent lot-to-lot and within-lot consistency for
high-quality homogeneous black shades
• Easy processing and support of a long-lasting
spin pack lifetime
• Fastness properties and specification tolerances
on par with high-end products on the market
• Standard and bluish undertones available
in high pigment loadings for an efficient and
competitive coloration package
• Can be combined with additives into a single
combination concentrate for convenience
• Compliance with global, regional, and local
standards and regulations*
RECOMMENDED USE
• In most cases, the concentrate is added
directly to the resin using gravimetric or
volumetric dosing units; for some processes,
the concentrate can be added via a side stream
extruder (direct spinning)
• The recommended dosages are from 3% for
the typical automotive, technical, and carpet
applications and up to 6% for apparel, footwear,
and home textile yarns
* Contact your local sales representative for more information on
regulatory compliance
PRODUCT BULLETIN
Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/2020-09/oncap-anti-fog-product-bulletin.pdf
MARKETS AND APPLICATIONS
OnCap anti-fog additives are formulated for use
in transparent packaging of chilled fresh foods
such as:
• Fresh fish
• Meats
• Vegetables
• Fruit
• Ready-to-eat meals
These anti-fog materials can be incorporated into:
• Lidding barrier film on rigid or
semi-rigid containers
• Stretch film
• Shrink film
• BOPP film
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2022-12/reSound Ultra Low Carbon Footprint TPE Product Bulletin_0.pdf
KEY CHARACTERISTICS
• Negative, neutral, or low PCF
• Available in 60 and 80 Shore A
• Performs like traditional TPEs
• Naturally opaque and easy to color
• Suitable to injection mold, or overmold onto
PP and PE
MARKETS & APPLICATIONS
The portfolio of reSound ultra-low carbon footprint
TPEs is ideal for brand owners and manufacturers
who prefer to use a more sustainable material in
personal care, household appliance, consumer
electronics, and consumer packaging applications.
https://www.avient.com/sites/default/files/2023-10/reSound REC Automotive Interior Grades Product Bulletin.pdf
KEY CHARACTERISTICS
• 35–45% PCR/PIR content
• Meet automotive standards for VOC, FOG,
and odor
• Colored black, additional colors are possible
• Customizable formulations
• Overmoldable to PP
MARKETS & APPLICATIONS
The reSound REC 7310 series provides a more
sustainable TPE choice for automotive interior
components and delivers comparable performance
to their traditional counterparts.
https://www.avient.com/sites/default/files/2020-09/oncap-hc-product-bulletin.pdf
KEY CHARACTERISTICS
• Formulated specifically for healthcare product
applications
• Wide portfolio of polymer additive solutions,
including:
- Antimicrobial technology
- Surface energy modification, including
low retention
- Authentication technology
- Lasermarking
- Sterilization and content protection
- Processing optimization
- FDA compliant resin and color changeover
solutions
• OnCap HC Plus certified for USP Class VI and ISO
10993 bio-compatibility requirements; includes
anti-oxidant, lasermarking, antimicrobial,
radiopacifier, anti-stat, and polymer and
gamma stabilization performance additives
OnCap™ HC & OnCap™ HC Plus
Additives for Healthcare
PRODUCT BULLETIN
INDUSTRY SUPPORT
• Supported with a broad range of technical support
and services:
- Restricted medical-grade raw material
selection process
- Sampling program
- World-class FDA cGMP manufacturing facilities
- Batch traceability and formulation
lockdown systems
- FDA Drug Master Files or Medical Device
Files maintenance
MARKETS AND APPLICATIONS
OnCap HC and OnCap HC Plus Additives are an
excellent choice for medical devices and parts,
pharmaceutical or cosmetic packaging, and many other
healthcare related polymer applications.
https://www.avient.com/sites/default/files/2024-07/Cesa and Hiformer Non-PFAS Process Aid Product Bulletin.pdf
Certain PFAS materials are subject to product bans,
leading to market exits by suppliers.
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_DE2.pdf
Einige Beispiele:
• Einnahmen oder Schätzungen oder sonstige
Finanzinformationen vor ihrer öffentlichen Freigabe
• Erhebliche Änderungen des Betriebsniveaus
• Diskussionen über wichtige Transaktionen, einschließlich
Akquisitionen, Joint-Ventures oder Veräußerungen
• Informationen über unsere finanzielle
Verfassung, Prognosen und Pläne, Marketing- und
Verkaufsprogramme und F & E-Informationen
• Veränderungen in der oberen Geschäftsführung, die noch
nicht öffentlich bekannt gegeben worden sind
• Vergabe oder Aufhebung wichtiger Verträge mit Kunden
oder Lieferanten
• Anstehende Produkte oder neue Produkte,
Dienstleistungen oder Verfahren
• Das Bestehen von wichtigen Aufsichtsverfahren,
Regierungsermittlungen und Gerichtsverfahren unter
Beteiligung des Unternehmens und Entwicklungen mit
Bezug zu solchen Verfahren
VERHALTENSKODEX | 18
INHALTSANGABE
EINLEITUNG
UNSER
VERHALTENSKODEX
RESPEKT FÜR ALLE
EHRLICHKEIT BEI
DER ARBEIT
INTEGRITÄT IN
UNSEREM GESCHÄFT
SOZIALE
VERANTWORTUNG
DES UNTERNEHMENS
RESSOURCEN
Politische Spended/Aktivitäten und
gemeinnützige Spenden
Avient fordert Sie auf, über wichtige Themen informiert zu bleiben,
zu wählen und sich am politischen Prozess zu beteiligen.
A: Ja, Sie müssen die Beziehung offenlegen, damit Avient
potenzielle Konflikte bewerten und eindämmen kann.
https://www.avient.com/sites/default/files/2022-02/Q4 2021 Avient Earnings Release_0.pdf
Avient’s performance in this environment has been
differentiated as a result of our specialty focus, end market transformation and excellence in
execution.”
Factors that could cause
actual results to differ materially from those implied by these forward-looking statements include
disruptions, uncertainty or volatility in the credit markets that could adversely impact the
availability of credit already arranged and the availability and cost of credit in the future; the effect
on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory
risks; the current and potential future impact of the COVID-19 pandemic on our business, results
of operations, financial position or cash flows including without any limitation, any supply chain
and logistics issues; changes in polymer consumption growth rates and laws and regulations
regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices,
quality and supply, and in energy prices and supply; production outages or material costs
associated with scheduled or unscheduled maintenance programs; unanticipated developments
that could occur with respect to contingencies such as litigation and environmental matters; our
ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
information systems failures and cyberattacks; and amounts for cash and non-cash charges
related to restructuring plans that may differ from original estimates, including because of timing
changes associated with the underlying actions.
Three Months Ended
December 31,
2021 2020
Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1)
Net income from continuing operations attributable to Avient shareholders $ 29.8 $ 0.32 $ 74.2 $ 0.81
Special items, after tax (Attachment 3) 24.0 0.26 (26.7) (0.29)
Adjusted net income / EPS - excluding special items $ 53.8 $ 0.58 $ 47.5 $ 0.52
(1) Per share amounts may not recalculate from figures presented herein due to rounding
Year Ended
December 31,
2021 2020
Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1)
Net income from continuing operations attributable to Avient shareholders $ 230.8 $ 2.51 $ 132.0 $ 1.46
Special items, after tax (Attachment 3) 50.0 0.54 24.8 0.27
Adjusted net income / EPS - excluding special items $ 280.8 3.05 $ 156.8 1.73
(1) Per share amounts may not recalculate from figures presented herein due to rounding
8
Attachment 2
Avient Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
December 31,
Year Ended
December 31,
2021 2020 2021 2020
Sales $ 1,201.5 $ 997.0 $ 4,818.8 $ 3,242.1
Cost of sales 948.4 744.1 3,719.2 2,457.8
Gross margin 253.1 252.9 1,099.6 784.3
Selling and administrative expense 179.1 187.9 718.4 595.0
Operating income 74.0 65.0 381.2 189.3
Interest expense, net (17.5) (19.3) (75.3) (74.6)
Other (expense) income, net (5.4) 11.7 (1.3) 24.3
Income from continuing operations before income taxes 51.1 57.4 304.6 139.0
Income tax (expense) benefit (22.2) 17.3 (74.0) (5.2)
Net income from continuing operations 28.9 74.7 230.6 133.8
Income (loss) from discontinued operations, net of income taxes — 0.1 — (0.4)
Net income 28.9 74.8 230.6 133.4
Net loss (income) attributable to noncontrolling interests 0.9 (0.5) 0.2 (1.8)
Net income attributable to Avient common shareholders $ 29.8 $ 74.3 $ 230.8 $ 131.6
Earnings per share attributable to Avient common shareholders - Basic:
Continuing operations $ 0.33 $ 0.81 $ 2.53 $ 1.47
Discontinued operations — — — (0.01)
Total $ 0.33 $ 0.81 $ 2.53 $ 1.46
Earnings per share attributable to Avient common shareholders - Diluted:
Continuing operations $ 0.32 $ 0.81 $ 2.51 $ 1.46
Discontinued operations — — — (0.01)
Total $ 0.32 $ 0.81 $ 2.51 $ 1.45
Cash dividends declared per share of common stock $ 0.2375 $ 0.2125 $ 0.8750 $ 0.8200
Weighted-average shares used to compute earnings per common share:
Basic 91.5 91.4 91.4 90.1
Diluted 92.4 92.1 92.1 90.6
9
Attachment 3
Avient Corporation
Summary of Special Items (Unaudited)
(In millions, except per share data)
Special items (1)
Three Months Ended
December 31,
Year Ended
December 31,
2021 2020 2021 2020
Cost of sales:
Restructuring costs, including accelerated depreciation $ (6.0) $ (1.8) $ (14.6) $ (4.3)
Environmental remediation costs (0.5) (1.1) (22.9) (20.4)
Reimbursement of previously incurred environmental costs — — 4.5 8.7
Acquisition related costs 0.6 1.2 (0.6) (9.3)
Impact on cost of sales (5.9) (1.7) (33.6) (25.3)
Selling and administrative expense:
Restructuring, legal and other (4.2) (13.0) (5.9) (22.5)
Acquisition earn-out adjustments — 1.5 — (1.0)
Acquisition related costs (1.1) (1.4) (8.3) (24.9)
Impact on selling and administrative expense (5.3) (12.9) (14.2) (48.4)
Impact on operating income (11.2) (14.6) (47.8) (73.7)
Costs related to committed financing in interest expense, net — — — (10.1)
Other income, net — 0.1 0.1 0.4
Pension settlement/curtailment and mark-to-market adjustment (loss) gain (9.4) 10.3 (9.4) 17.2
Impact on income from continuing operations before income taxes (20.6) (4.2) (57.1) (66.2)
Income tax benefit (expense) on above special items 4.1 (1.3) 13.0 14.1
Tax adjustments(2) (7.5) 32.2 (5.9) 27.3
Impact of special items on net income from continuing operations
attributable to Avient Shareholders $ (24.0) $ 26.7 $ (50.0) $ (24.8)
Diluted earnings per common share impact of special items on net income
from continuing operations attributable to Avient shareholders $ (0.26) $ 0.29 $ (0.54) $ (0.27)
Weighted average shares used to compute adjusted earnings per share:
Diluted 92.4 92.1 92.1 90.6
(1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt
extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel
reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-
market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation
costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the
divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results
of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the
performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting
reported results
https://www.avient.com/sites/default/files/2022-03/Asia SEM Healthcare Product Selection Guide %281%29.pdf
This commitment is exemplified
by our No Surprises Pledge℠ which we make to all
customers and markets, across the globe
Contact Avient to tap into our material science expertise
and comprehensive product development support services
to help you bring your ideas to market faster.